lapatinib has been researched along with Actinic Reticuloid Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Andreu, I; García-Lainez, G; Marín, MP; Miranda, MA; Vayá, I | 1 |
1 other study(ies) available for lapatinib and Actinic Reticuloid Syndrome
Article | Year |
---|---|
In vitro assessment of the photo(geno)toxicity associated with Lapatinib, a Tyrosine Kinase inhibitor.
Topics: Activation, Metabolic; Animals; Antineoplastic Agents; BALB 3T3 Cells; Cell Survival; Comet Assay; Cytochrome P-450 CYP3A; Dealkylation; DNA Damage; Fibroblasts; Humans; Lapatinib; Mice; Oxidative Stress; Photochemical Processes; Photosensitivity Disorders; Protein Carbonylation; Protein Kinase Inhibitors; Skin | 2021 |